BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37853951)

  • 1. Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?
    Ghergus D; Martin M; Knapp AM; Delmotte F; Joublin-Delavat A; Jung S; Schickel JN; Mendel I; Dupuis A; Drénou B; Ghesquières H; Salles G; Baseggio L; Herbrecht R; Korganow AS; Vallat L; Soulas-Sprauel P; Meffre E; Martin T
    Am J Hematol; 2024 Jan; 99(1):48-56. PubMed ID: 37853951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
    Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
    Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T/B ratio does not reflect levels of ZAP70 expression in clonal CLL B-cells due to ZAP70 overexpression in patient T-cells.
    Rizzo D; Bouvier G; Youlyouz-Marfak I; Guerin E; Trimoreau F; Bordessoule D; Jaccard A; Gachard N; Feuillard J
    Cytometry B Clin Cytom; 2013 Mar; 84(2):125-32. PubMed ID: 23225571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZAP70 expression enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest by valency regulation of integrins.
    Laufer JM; Lyck R; Legler DF
    FASEB J; 2018 Sep; 32(9):4824-4835. PubMed ID: 29589978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic information and biological insights in chronic lymphocytic leukemia by high-resolution immunophenotypic analysis of ZAP70.
    Kaplan D; Sun Z; Tallman MS; Flinn IW; Xiao W; Caimi PF; Kaye NM; Lazarus HM
    Cytometry A; 2014 Sep; 85(9):798-808. PubMed ID: 24845539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel diagnostic biosensor for distinguishing immunoglobulin mutated and unmutated types of chronic lymphocytic leukemia.
    Ensafi AA; Amini M; Rezaei B; Talebi M
    Biosens Bioelectron; 2016 Mar; 77():409-15. PubMed ID: 26436328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZAP70 in B-CLL cells related to the expression in NK cells is a surrogate marker for mutational status.
    Wiggers TG; Westra G; Westers TM; Abbes AP; Strunk A; Kuiper-Kramer E; Poddighe P; van de Loosdrecht AA; Chamuleau ME
    Cytometry B Clin Cytom; 2014 Jul; 86(4):280-7. PubMed ID: 24924909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLL.
    Amin S; Walsh M; Wilson C; Parker AE; Oscier D; Willmore E; Mann D; Mann J
    J Cell Mol Med; 2012 Sep; 16(9):2074-84. PubMed ID: 22151263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
    Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
    Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of ZAP70 in chronic lymphocytic leukaemia activates NF-κB signalling.
    Pede V; Rombout A; Vermeire J; Naessens E; Vanderstraeten H; Philippé J; Verhasselt B
    Br J Haematol; 2013 Dec; 163(5):621-30. PubMed ID: 24219331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA.
    Stamatopoulos B; Haibe-Kains B; Equeter C; Meuleman N; Sorée A; De Bruyn C; Hanosset D; Bron D; Martiat P; Lagneaux L
    Haematologica; 2009 Jun; 94(6):790-9. PubMed ID: 19377082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
    Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
    Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression.
    Admirand JH; Knoblock RJ; Coombes KR; Tam C; Schlette EJ; Wierda WG; Ferrajoli A; O'Brien S; Keating MJ; Luthra R; Medeiros LJ; Abruzzo LV
    Mod Pathol; 2010 Nov; 23(11):1518-23. PubMed ID: 20657554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia.
    Stamatopoulos B; Meuleman N; Haibe-Kains B; Duvillier H; Massy M; Martiat P; Bron D; Lagneaux L
    Clin Chem; 2007 Oct; 53(10):1757-66. PubMed ID: 17702857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia.
    Pritsch O; Maloum K; Dighiero G
    Semin Oncol; 1998 Feb; 25(1):34-41. PubMed ID: 9482525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies.
    Leveille E; Chan LN; Mirza AS; Kume K; Müschen M
    Cell Signal; 2022 Jun; 94():110331. PubMed ID: 35398488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine Contents in Chronic Lymphocytic Leukemia: Association with ZAP70 Expression.
    Işıksaçan N; Çınar S; Aktaş Çetin E; Aktan M; Deniz G
    Turk J Haematol; 2016 Sep; 33(3):202-8. PubMed ID: 26376785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Igbeta(CD79b) mRNA expression in chronic lymphocytic leukaemia cells correlates with immunoglobulin heavy chain gene mutational status but does not serve as an independent predictor of clinical severity.
    Cajiao I; Sargent R; Elstrom R; Cooke NE; Bagg A; Liebhaber SA
    Am J Hematol; 2007 Aug; 82(8):712-20. PubMed ID: 17315213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL.
    Nichols EM; Jones R; Watson R; Pepper CJ; Fegan C; Marchbank KJ
    Oncotarget; 2015 Oct; 6(32):32669-80. PubMed ID: 26452134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?
    Strati P; Caligaris-Cappio F
    Curr Opin Oncol; 2011 Sep; 23(5):455-60. PubMed ID: 21681094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.